Fertility planning used to be separate from men's health optimization. Now, with more men starting TRT, GLP-1s, and multi-medication regimens in their thirties and early forties — prime fertility years — the collision between optimization goals and reproductive goals is unavoidable.
The central tension: testosterone replacement therapy suppresses sperm production, and many men don't learn this until they're already committed to a regimen. But TRT isn't the only fertility-relevant medication in the modern stack.
TRT and Fertility: The Core Conflict
Exogenous testosterone is a male contraceptive. This isn't a side effect — it's a well-documented pharmacological consequence. When external testosterone enters the body, the pituitary detects adequate androgen levels and reduces LH and FSH secretion. Without FSH stimulation, the Sertoli cells in the testes slow or stop supporting spermatogenesis. Sperm counts can drop to zero (azoospermia) in 40–60% of men on TRT, and significant oligospermia (reduced counts) occurs in the majority.
Recovery after stopping TRT is possible but not guaranteed and not fast. Most men recover spermatogenesis within 6–12 months after discontinuation, but some require up to 24 months, and a small percentage may not fully recover — particularly after prolonged use.
Fertility-Preserving Alternatives to TRT
Enclomiphene
Enclomiphene is a selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the hypothalamus and pituitary, increasing LH and FSH secretion, which stimulates endogenous testosterone production and preserves spermatogenesis. It raises testosterone while maintaining — or even improving — sperm production.
The limitation: enclomiphene is not FDA-approved for hypogonadism (it's the active isomer of clomiphene, which has been used off-label for decades). Access is through compounding pharmacies, and the regulatory future is uncertain.
HCG (Human Chorionic Gonadotropin)
HCG mimics LH, directly stimulating the Leydig cells to produce testosterone without suppressing pituitary FSH. When used alongside TRT, HCG maintains intratesticular testosterone levels sufficient to support spermatogenesis in many (though not all) men.
The standard protocol: 500–1000 IU HCG subcutaneously, two to three times per week, alongside TRT. This doesn't guarantee fertility preservation, but it significantly improves the odds compared to TRT alone.
HCG availability has been complicated by the FDA's 2020 classification of HCG as a biologic (requiring BLA approval for commercial production), which removed it from traditional compounding pharmacy supply chains. Compounding pharmacies can still produce HCG under certain conditions, but supply is less predictable than before.
Natesto (Nasal Testosterone)
Nasal testosterone (Natesto) has been marketed as fertility-preserving based on its short-acting pharmacokinetics — the rapid absorption and clearance may produce less sustained HPG axis suppression than injectable testosterone. Some published data supports maintained spermatogenesis in a subset of users. However, the evidence is limited, and Natesto isn't proven fertility-safe in controlled trials.
Other Medications in the Stack: Fertility Impact
| Medication | Fertility Impact | Recommendation |
|---|---|---|
| GLP-1 agonists | No direct fertility impact known; weight loss may improve fertility | Generally safe; beneficial if obesity is impairing reproductive function |
| Finasteride | Reduces semen volume; rare reports of sperm quality effects | Discontinue 3+ months before attempting conception as a precaution |
| PDE5 inhibitors | No negative fertility impact; some data suggests improved sperm motility | Safe to continue |
| Sermorelin | No established fertility impact | Likely safe, but limited data in reproductive-age men |
| NAD+/NMN | Preclinical data suggests potential benefit to sperm quality | Insufficient human data; no known harm |
The Fertility-Planning Protocol
If You're on TRT and Want to Conceive
- Timeline: Plan 6–12 months ahead. Spermatogenesis recovery takes time.
- Get a semen analysis now: Establish your current sperm count and quality before making changes.
- Options: (a) Stop TRT and switch to enclomiphene or HCG monotherapy; (b) Add HCG to existing TRT; (c) Stop TRT and use no replacement during the recovery period.
- Monitor with semen analyses: Repeat every 2–3 months to track recovery.
- Consult a reproductive urologist: For men with complex protocols or prolonged TRT use, specialist guidance optimizes recovery timelines.
If you haven't started TRT yet and may want children: Consider banking sperm before starting TRT as insurance. The cost ($500–$1,000 for collection and initial storage, $200–$500/year for ongoing storage) is modest compared to the potential cost of fertility treatment if natural recovery is incomplete.
The Bottom Line
Plan Before You Prescribe
TRT suppresses fertility — this is certain. Recovery is usually possible but not guaranteed. Every man starting TRT who may want biological children in the future should either (a) bank sperm before starting, (b) use HCG alongside TRT, or (c) choose fertility-preserving alternatives like enclomiphene. The conversation about fertility should happen before the first testosterone injection, not after years of use when conception fails.